How much funding has Rubicon Research raised?

Rubicon Research has raised $100.0M in total funding, most recently a Growth Equity round.

Who are Rubicon Research's investors?

Rubicon Research's investors include General Atlantic.

When was Rubicon Research founded?

Rubicon Research was founded in 1999.

Where is Rubicon Research headquartered?

Rubicon Research is headquartered in Thane, India.

What industry is Rubicon Research in?

Rubicon Research operates in Life Sciences.

Rubicon Research

IPO

Thane, India · Founded 1999 · $100.0M raised

Life Sciences

Headquarters: Thane
Founded: 1999
Business Model: B2B
Website: rubicon.co.in

Total Funding: $100.0M
Last Round: $100.0M Growth EquityJan 2019
Rounds: 1

About

Rubicon Research is a pharmaceutical formulations company driven by innovation through focused research and development, with a growing portfolio of specialty products and drug-device combination products targeting regulated markets. As of March 31, 2024, it had 55 commercialized products in the US across 69 active NDAs and ANDAs, spanning oral capsules, concentrates, solutions, suspensions, syrups, tablets, ophthalmic drops, and intrathecal injections. Its proprietary drug-delivery technologies are backed by 10 patents across India and the US.

Summary

Rubicon Research is a Life Sciences company based in Thane, India, founded in 1999. It has raised $100.0M in total across 1 round, most recently a $100.0M Growth Equity round in Jan 2019. Investors include General Atlantic.